‘Keep the guardrails on’: As AI use expands in IBD care, physicians should remain cautious

Artificial intelligence has been used extensively in gastroenterology for polyp detection and is expanding into the inflammatory bowel disease space in an experimental and “research phase,” quickly making its way into clinical use.“AI encompasses several different technologies that can engage text, images and other data with initial use cases aiming to reproduce expert opinion with…

AI shows promise in diagnosis, treatment of IBD, but limitations, concerns remain

Artificial intelligence has been used in various ways to benefit patients with inflammatory bowel disease, with one of the main applications being the prediction and diagnosis of disease.AI algorithms have been developed to analyze patient data, including medical histories, laboratory tests and imaging results, and to identify patterns and predict the likelihood of a patient…

|

Discover the Future of Gastroenterology at the 58th Florida Gastroenterologic Society Annual Meeting

As healthcare professionals, staying updated with the latest advancements in gastroenterology and hepatology can be a daunting task. The rapid pace of medical innovation requires constant learning and re-education. Moreover, the task of earning Continuous Medical Education (CME) credits and Maintenance of Certification (MOC) points is a significant challenge. If you’re facing these problems, we…

Obesity medication use plummets after bariatric surgery; cardiovascular drug use rebounds

Patients who underwent bariatric surgery for morbid obesity had a “substantial and long-lasting reduction” of lipid-lowering and antidiabetic medication use compared with patients who did not undergo surgery.“Bariatric surgery decreases the prevalence of obesity-related diseases, contributing to longer life expectancy and increasing use of such surgery in patients with morbid obesity,” Joonas H. Kauppila, MD,…